Non HDL-C as the Primary Target for LipidLowering Therapy: Moving beyond LDLCentric Management
Journal Title: Indian Journal of Cardio Biology & Clinical Sciences - Year 2015, Vol 2, Issue 1
Abstract
The value of lowering low-density lipoprotein cholesterol (LDL-C) is widely known with a large number of studies demonstrating benefit of LDL-C lowering in a wide range of patient populations. Accordingly, LDL-C has been the focus of lipid lowering therapy for a long period. However, recent data suggest that non-high density lipoprotein cholesterol (non-HDL-C) may be a better target for lipid management than LDL-C. Unlike LDL-C, non-HDL-C includes all atherogenic particles present in blood and therefore provides more complete estimation of cardiovascular risk, esp. in patients with atherogenic dyslipidemia or those already on statin therapy. Further, measurement of non-HDL-C is simple, no extra blood test is required and there is no need for fasting sampling.
Authors and Affiliations
Manish Bansal
Keywords
Related Articles
- EP ID EP195113
- DOI -
- Views 111
- Downloads 0
Genetic Aspect of Clopidogrel Resistance: An Indian Scenario
Clopidogrel is an oral, thienopyridine class anti-platelet agent used to inhibit blood clots and is one of the most widely used in patients with coronary artery disease, peripheral vascular diseases, and cerebrovascular...
The Role of the Notch Pathway in Atherosclerosis
Atherosclerosis is one of the primary causes of heart disease and stroke. In industrialized countries, it is the underlying cause of about 50% of all deaths. Atherosclerosis can be considered a form of chronic inflammati...
From Reperfusion to Regeneration and Beyond
The pathophysiology of AMI is a thrombotic occlusion of coronary artery leading to death of heart muscles. The treatment therefore aims at restoration of the blood supply by reopening the artery that can be achieved phar...
Non HDL-C as the Primary Target for LipidLowering Therapy: Moving beyond LDLCentric Management
The value of lowering low-density lipoprotein cholesterol (LDL-C) is widely known with a large number of studies demonstrating benefit of LDL-C lowering in a wide range of patient populations. Accordingly, LDL-C has been...
Pathophysiology of Coronary Microvascular Dysfunction
Coronary microvascular dysfunction is a group of disorders with heterogenous pathophysiology. At present there are no methods to pinpoint the underlying structural and functional disorder in a given patient. Identificati...